AYSEGUL ORUC, MEHMET FETHULLAH AYDIN, ABDULMECİT YILDIZ, MAHMUT YAVUZ, MUSTAFA GULLULU, KAMİL DILEK, ALPARSLAN ERSOY
Turkish Journal of Internal Medicine - 2020;2(4):118-122
Background Hypervolemia is an important consequence of heart failure (HF) that leads poor quality of life and frequent hospitalizations. Ultrafiltration (UF) with dialysis is an option for HF patients who are resistant or inappropriate for diuretics. Peritoneal dialysis (PD) can be a long-term efficient solution for hypervolemia in appropriate HF patients. Material and Methods We retrospectively evaluated PD patients in our center in order to determine the ones whose indication was UF for volume control because of HF between January 2015 and January 2020. Results 4 (2 females, 68.75±4.27 years old) HF patients who had poor volume control on diuretic based regimen were on PD for UF. PD treatment was planned as a daily single exchange with icodextrin in whom all had preserved renal function. In one patient one daily exchange with an amino acid-based PD solution was added. Exchange volume was between 1000 and 1500 mL, dwell time was 9 to 14 hours and UF was 200 to 1100 mL. During the follow-up patients lost adequate weight and none of them were hospitalized because of hypervolemia. Conclusions UF through PD in HF patients provides effective volume control, relief of symptoms and avoids frequent hospitalizations. A single daily exchange with icodextrin can be adequate for hypervolemic, well selected HF patients.
